Iovance Biotherapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Iovance Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iovance Biotherapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Iovance Biotherapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $11M | 3.2M | 3.51 |
| 2025-12-31 | $3.3M | 1.2M | 2.73 |
| 2025-09-30 | $4.5M | 2.1M | 2.17 |
| 2025-06-30 | $3.6M | 2.1M | 1.72 |
| 2025-03-31 | $8.0M | 2.4M | 3.33 |
| 2024-12-31 | $19M | 2.6M | 7.40 |
| 2024-09-30 | $29M | 3.1M | 9.39 |
| 2024-06-30 | $28M | 3.5M | 8.02 |
| 2024-03-31 | $78M | 5.3M | 14.82 |
| 2023-12-31 | $27M | 3.3M | 8.13 |
| 2023-09-30 | $16M | 3.6M | 4.55 |
| 2023-06-30 | $26M | 3.7M | 7.04 |
| 2023-03-31 | $23M | 3.8M | 6.11 |
| 2022-12-31 | $25M | 3.8M | 6.39 |
| 2022-03-31 | $86M | 5.2M | 16.65 |
| 2021-12-31 | $89M | 4.7M | 19.09 |
| 2021-09-30 | $114M | 4.6M | 24.66 |
| 2021-06-30 | $121M | 4.7M | 26.02 |
| 2021-03-31 | $163M | 5.1M | 31.66 |
| 2020-12-31 | $343M | 7.4M | 46.40 |
| 2020-09-30 | $228M | 6.9M | 32.92 |
| 2020-06-30 | $200M | 7.3M | 27.45 |
| 2020-03-31 | $203M | 6.8M | 29.94 |
| 2019-12-31 | $180M | 6.5M | 27.68 |
| 2019-09-30 | $118M | 6.5M | 18.20 |
| 2019-06-30 | $148M | 6.0M | 24.52 |
| 2019-03-31 | $33M | 3.5M | 9.51 |
| 2018-12-31 | $29M | 3.3M | 8.85 |
| 2018-09-30 | $35M | 3.1M | 11.25 |
| 2018-06-30 | $42M | 3.3M | 12.80 |
| 2018-03-31 | $30M | 1.7M | 16.90 |